Patent ID: 11882829
Assignee: SPOGEN BIOTECH INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 0:
1. A recombinant Bacillus cereus family member that expresses a fusion protein, wherein the fusion protein comprises:
a targeting sequence, exosporium protein, or exosporium protein fragment that targets the fusion protein to the exosporium of the recombinant Bacillus cereus family member selected from the group consisting of:
(a) an amino acid sequence having at least about 43% identity with amino acids 20-35 of SEQ ID NO: 1, wherein the identity with amino acids 25-35 is at least about 54%;
(b) a targeting sequence comprising amino acids 1-35 of SEQ ID NO: 1;
(c) a targeting sequence comprising amino acids 20-35 of SEQ ID NO: 1;
(d) a targeting sequence comprising SEQ ID NO: 1;
(e) a targeting sequence comprising SEQ ID NO: 60;
(f) a targeting sequence comprising amino acids 22-31 of SEQ ID NO: 1;
(g) a targeting sequence comprising amino acids 22-33 of SEQ ID NO: 1; and
(h) a targeting sequence comprising amino acids 20-31 of SEQ ID NO: 1; and
a catalase.